1.
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
by Suissa, Samy
Thorax, 2012, Vol.67 (11), p.957-963
2.
Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study
by Gershon, Andrea S, Dr
The Lancet (British edition), 2011, Vol.378 (9795), p.991-996
3.
Chronic obstructive pulmonary disease
by Decramer, Marc, Prof
The Lancet (British edition), 2012, Vol.379 (9823), p.1341-1351
4.
Oxidative stress–induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease
by Wiegman, Coen H., PhD
Journal of allergy and clinical immunology, 2015, Vol.136 (3), p.769-780
5.
Determinants and outcomes of physical activity in patients with COPD: a systematic review
by Gimeno-Santos, Elena
Thorax, 2014, Vol.69 (8), p.731-9
6.
Asthma in older adults
by Gibson, Peter G, Prof
The Lancet (British edition), 2010, Vol.376 (9743), p.803-813
7.
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes
by Garcia-Aymerich, Judith
Thorax, 2011, Vol.66 (5), p.430-11
8.
The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease
by Steer, John
Thorax, 2012, Vol.67 (11), p.970-976
9.
Chronic obstructive pulmonary disease
by Rabe, Klaus F, Prof
The Lancet (British edition), 2017, Vol.389 (10082), p.1931-1940
11.
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
by Barnes, Peter J., FRS, FMedSci
Journal of allergy and clinical immunology, 2016, Vol.138 (1), p.16-27
12.
Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease
by Dicker, Alison J., PhD
Journal of allergy and clinical immunology, 2017
13.
Risk factors and early origins of chronic obstructive pulmonary disease
by Postma, Dirkje S, Prof
The Lancet (British edition), 2015, Vol.385 (9971), p.899-909
14.
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome
by Guinea, J
Clinical microbiology and infection, 2010, Vol.16 (7), p.870-877
15.
Global burden of COPD: risk factors, prevalence, and future trends
by Mannino, David M, Dr
The Lancet (British edition), 2007, Vol.370 (9589), p.765-773
16.
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
by Barnes, Peter J., FRS, FMedSci
Journal of allergy and clinical immunology, 2013, Vol.131 (3), p.636-645
17.
Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial
by Holland, Anne E
Thorax, 2017, Vol.72 (1), p.57-65
18.
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
by Pavord, Ian D
Thorax, 2016, Vol.71 (2), p.118-125
20.
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
by Mayhew, David
Thorax, 2018, Vol.73 (5), p.422-430
